ArticleJournal of atherosclerosis and thrombosis2024
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.
Abstract read
In one paragraph
Article in Journal of atherosclerosis and thrombosis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
170 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Effect of Intake of Lycopene-Containing Products on Vascular Endothelial Function in Healthy Adults: A Systematic Review with Meta-Analysis.Nutrients · 2026Pooled it
- Association of Social Participation with Cardiovascular Risk Factors: A Systematic Review.Journal of atherosclerosis and thrombosis · 2025Pooled it
- Association between the High-density Lipoprotein Cholesterol Efflux Capacity and the Long-term Prognosis in Patients with Coronary Artery Disease: A Meta-analysis.Journal of atherosclerosis and thrombosis · 2025Pooled it
- The Effects of Pemafibrate on Fibrinogen and Thrombogenicity in Patients with Coronary Artery Disease.Journal of atherosclerosis and thrombosis · 2026Trial
- Long-term Safety and Efficacy of Bempedoic Acid in Japanese Patients with Hypercholesterolemia: the CLEAR-J LONG.Journal of atherosclerosis and thrombosis · 2026Trial
- Efficacy of a multidomain intervention in older adults with vascular risks: The Japan-Multimodal Intervention Trial for the Prevention of Dementia (J-MINT).Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Trial
- Effects of Pemafibrate on Cholesterol Synthesis and Absorption: a Post-Hoc Subgroup Analysis of a Phase 2 Clinical Trial.Journal of atherosclerosis and thrombosis · 2025Trial
- Efficacy and Safety of Bempedoic Acid for Hypercholesterolemia in Japan: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Trial.Journal of atherosclerosis and thrombosis · 2025Trial
- Long-Term Effects of Extended-Release Pemafibrate Tablets on Dyslipidemia and Safety in Triglyceridemic Patients: A Phase 3, Multicenter, Randomized, Open-Label, Parallel-Group Study.Journal of atherosclerosis and thrombosis · 2025Trial
- Effects of Pemafibrate on LDL-C and Related Lipid Markers in Patients with MASLD: A Sub-Analysis of the PEMA-FL Study.Journal of atherosclerosis and thrombosis · 2025Trial
- Adequate Vegetable Intake Improves Metabolic Indices in Healthy Japanese Participants: A Randomized Crossover Study.Journal of atherosclerosis and thrombosis · 2025Trial
- Pharmacokinetics and Safety of Pemafibrate in Patients with both Dyslipidemia and Severe Renal Impairment: A Phase 4 Study.Journal of atherosclerosis and thrombosis · 2025Trial
- Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial.Journal of atherosclerosis and thrombosis · 2024Trial
- Obicetrapib as an Adjunct to Stable Statin Therapy in Japanese Subjects: Results from a Randomized Phase 2 Trial.Journal of atherosclerosis and thrombosis · 2024Trial
- Efficacy of acupuncture in patients with carotid atherosclerosis: a randomized controlled clinical trial.BMC complementary medicine and therapies · 2024Trial
- Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial.Journal of atherosclerosis and thrombosis · 2024Trial
- Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial.Journal of atherosclerosis and thrombosis · 2023Trial
- Association between serum lipoprotein(a) levels and aortic vulnerable plaques assessed by non-obstructive general angioscopy.Atherosclerosis plus · 2026Article
- Article
- Cardiovascular risk scores estimate arterial thrombotic risk in aging adults with hemophilia in the ADVANCE Japan cohort.Blood advances · 2026Article
110 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors.
Tomonori OkamuraPreventive Medicine and Public Health, Keio University School of Medicine.
Kazuhisa TsukamotoDepartment of Internal Medicine, Teikyo University School of Medicine.
Hidenori AraiNational Center for Geriatrics and Gerontology.
Yoshio FujiokaFaculty of Nutrition, Division of Clinical Nutrition, Kobe Gakuin University.
Yasushi IshigakiDivision of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Iwate Medical University.
Shinji KobaDivision of Cardiology, Department of Medicine, Showa University School of Medicine.
Hirotoshi OhmuraDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine.
Tetsuo ShojiDepartment of Vascular Medicine, Osaka Metropolitan University Graduate school of Medicine.
Koutaro YokoteDepartment of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine.
Hiroshi YoshidaDepartment of Laboratory Medicine, The Jikei University Kashiwa Hospital.
Masayuki YoshidaBioethics Research Center, Tokyo Medical and Dental University.
Juno DeguchiDepartment of Vascular Surgery, Saitama Medical Center, Saitama Medical University.
Kazushige DobashiDepartment of Pediatrics, School of Medicine, University of Yamanashi.
Akira FujiyoshiDepartment of Hygiene, Wakayama Medical University.
Hirotoshi HamaguchiDepartment of Neurology, Kita-Harima Medical Center.
Masumi HaraDepartment of Internal Medicine, Mizonokuchi Hospital, Teikyo University School of Medicine.
Mariko Harada-ShibaCardiovascular Center, Osaka Medical and Pharmaceutical University.
Takumi HirataInstitute for Clinical and Translational Science, Nara Medical University.
Mami IidaDepartment of Internal Medicine and Cardiology, Gifu Prefectural General Medical Center.
Yoshiyuki IkedaDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University.
Shun IshibashiDivision of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University, School of Medicine.
Hideyuki KandaDepartment of Public Health, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.
Shinji KiharaMedical Laboratory Science and Technology, Division of Health Sciences, Osaka University graduate School of medicine.
Kazuo KitagawaDepartment of Neurology, Tokyo Women's Medical University Hospital.
Satoru KodamaDepartment of Prevention of Noncommunicable Diseases and Promotion of Health Checkup, Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine.
Masahiro KosekiDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
Yoshiro MaezawaDepartment of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine.
Daisaku MasudaDepartment of Cardiology, Center for Innovative Medicine and Therapeutics, Dementia Care Center, Doctor's Support Center, Health Care Center, Rinku General Medical Center.
Takashi MiidaDepartment of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine.
Yoshihiro MiyamotoOpen Innovation Center, National Cerebral and Cardiovascular Center.
Rimei NishimuraDepartment of Diabetes, Metabolism and Endocrinology, The Jikei University School of Medicine.
Koichi NodeDepartment of Cardiovascular Medicine, Saga University.
Midori NoguchiDivision of Public Health, Department of Social Medicine, Graduate School of Medicine, Osaka University.
Mitsuru OhishiDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University.
Isao SaitoDepartment of Public Health and Epidemiology, Faculty of Medicine, Oita University.
Shojiro SawadaDivision of Metabolism and Diabetes, Faculty of Medicine, Tohoku Medical and Pharmaceutical University.
Hirohito SoneDepartment of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine.
Minoru TakemotoDepartment of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare.
Akihiko WakatsukiDepartment of Obstetrics and Gynecology, Aichi Medical University.
Hidekatsu YanaiDepartment of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AtherosclerosisCardiovascular DiseasesHumansJapanSocieties, Medical
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.